MAPK7 and breast carcinoma: A previous report demonstrated that miR-143 suppresses ERK5 in acute myeloid lymphoma, breast cancer, HeLa cell, bladder cancer, and adipose tissue-derived stromal cells [14,15,16,17,18,19].